The Study of Corporate Growth: 75 Years of Core Managerial Competences and Business Diversification by Daewoong Pharmaceutical
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
This study examines Daewoong Pharmaceutical’s domestic and foreign business performance, and surveys and analyzes the background of the development of its driving forces. It presents the standard business direction by considering the core competencies and business strategies that made it able to rebound as a leading ETC pharmaceutical company in Korea, and then a global pharmaceutical company. Hence, we divided its core competencies based on the value chains across the 75 years of the company’s history. Moreover, achieving continuous corporate growth through a business diversification strategy has allowed it to aim to optimize the value chain such that it can grow further on a global scale in the long-term, concentrate in Research and Development in the mediumand long-terms, focus on marketing in the medium- and short-terms, and foster marketing-based distribution in the short-term. With its current management strategy, the company has been able to add fuel to the fire on both domestic and foreign markets, and will continue to grow and maintain its position as a leading pharmaceutical company in the global market in the future. This research paper is a good reference for companies that have difficulties in achieving localization due to different government regulations.
Abstract
This study examines Daewoong Pharmaceutical’s domestic and foreign business performance, and surveys and analyzes the background of the development of its driving forces. It presents the standard business direction by considering the core competencies and business strategies that made it able to rebound as a leading ETC pharmaceutical company in Korea, and then a global pharmaceutical company. Hence, we divided its core competencies based on the value chains across the 75 years of the company’s history. Moreover, achieving continuous corporate growth through a business diversification strategy has allowed it to aim to optimize the value chain such that it can grow further on a global scale in the long-term, concentrate in Research and Development in the mediumand long-terms, focus on marketing in the medium- and short-terms, and foster marketing-based distribution in the short-term. With its current management strategy, the company has been able to add fuel to the fire on both domestic and foreign markets, and will continue to grow and maintain its position as a leading pharmaceutical company in the global market in the future. This research paper is a good reference for companies that have difficulties in achieving localization due to different government regulations.
참고문헌 (45)
- Ahn Chun Sik, "A Study on the Life and Management Ideology of Daewoong Pharmaceutical by Yoon Young Hwan", Management History Research, 11, pp.257~285 (1995)
- Bleeke, J., "Collaborating to Compete : Using Strategic Alliances and Acquisitions in the Global Marketplace" (1993), John Wiley & Sons
- Choi Min Young, "A Case of Knowledge Management Activation in Pharmaceuticals", pp.163~172 (2010), Knowledge Management Research
- Dr. Seok Won, "Influence Factor of Effect Analysis and Pharmaceutical Industry in Drugs Related Policy", Doctor
- DiMasi, J. A., "R&D Cost, Innovative Output and Firm Size in the Pharmaceutical Industry", International Journal of the Economics of Business, 2(2), pp.201~219 (1995)
- Graves, S. B., "Innovative Productivity and Returns to Scale in the Pharmaceutical Industry", Strategic Management Journal, 14(8), pp.593~605 (1993)
- Ghoshal, S., "The Multinational Corporation as an Interorganizational Network", Academy of Management Review, 15(4), pp.603~625 (1990)
- Hwang Myung Soo, "Yu Il-Hwan’s Life and Management Ideology", Management History, 9(9) (1994)
- Han Hyung Ho, "Management Core Competency Analysis in 80 Years of Dong-A Pharmaceuticals", Business History, 30(1), pp.79~109 (2015)
- Jo Hae In, "The Strategy and Success Factors of Pharmaceutical Company for Overseas Expansion: Focusing on Cases of Daewoong Pharmaceutical", 기업경제연구, 46, pp.23~41 (2017)
- Kim Moon Tae, "The Effect of Pharmaceutical Industry on the Profit Management of Capital Studies into R & D Expense", Financial and Accounting Information Journal, 16(1), pp.79~98 (2016)
- Pharmaceutical Industry Analysis Report in 2017, "Kim Soo Bum", Health Industry Development Institute, ~, pp.own –Drugs-2017-85 (2017)
- Kim Shin Woong, "The Growth and Development of Choongwae Pharmaceuticals", Korean Academy of Business Historians, 11, pp.201~256 (1995)
- 국승규, "전문경영인 일동제약 이정치 회장의 제약활동과 경영이념", 전문경영인연구, 15(3), pp.137~164 (2012), 한국전문경영인학회
- Ko Seung Hee, "Modern Historical Illumination of Entrepreneurs in the Growth and Development Process of Donghak Pharmaceutical", Business History, 22(2), pp.51~132 (2007)
- 이경민, "우리나라 제약산업의 연구개발(R&D)투자가 기업성과에 미치는 영향", 전문경영인연구, 10(2), pp.81~100 (2007), 한국전문경영인학회
- 이동수, "기업규모와 기술혁신활동 : 슘페터 가설의 재조명", 산업경제연구, 27(6), pp.2513~2532 (2014), 한국산업경제학회
- Lee Seung Wook, "The Growth and Development of Boryeong Group", Management History, 18(2), pp.51~118 (2003)
- 이은서, "제약기업의 연구개발비 자산화 비교", 회계정보연구, 33(2), pp.141~159 (2015), 한국회계정보학회
- Mahlich, J. C., "The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan", Review of Industrial Organization, 28(2), pp.145~164 (2006)
- Nonaka I., "A dynamic theory of organizational knowledge creation", Organizational Science, 5 (1994)
- Nonaka I., "A Dynamic Theory of Organizational Knowledge Creation", Organization Science, pp.14~37 (1994)
- Pan, Y., "The Hierarchical Model of Market Entry Modes", Journal of International Business Studies, 31, pp.535~554 (2000)
- Prahalad, C. K., "Multinational Mission: Balancing Local Demands and Global Vision" (1987), Free Press
- 류두원, "국제 전략적제휴가 기업성과에 미치는 영향: 회계적 변수를 기반으로 한 제휴유형간 차이 분석을 중심으로", 국제경영연구, 28(1), pp.59~88 (2017), 한국국제경영학회[DOI]
- 신규환, "1950-60년대 한국 제약산업과 일반의약품시장의 확대", 의사학, 24(3), pp.749~782 (2015), 대한의사학회[DOI]
- Spender, J. C., "The Multinational Enterprise as a Loosely Coupled System: The Global Integration-Local Responsiveness Dilemma", Management Finance, 25(2), pp.63~84 (1999)
- Todeva, E., "Strategic Alliances and Models of Collaboration", Management Decision, 43, pp.123~148 (2005)
- Vandergrift, M., "Health policy versus industrial policy in the pharmaceutical sector: the case of Canada", Health Policy, 41(3), pp.241~260 (1997)
- Westney, D. E., "Organization theory and the multinational corporation", pp.53~76 (1993), Palgrave Macmillan
- Young, C., "Organization theory and the multinational corporation" (2016), Springer
- Business Post, "Daewoong Pharmaceuticals and Speed - Add to Osong Smart Plant as Outpost Global Company", Business Post(2019.07.26.), ~ (2019)
- Dong-A Ilbo, "Fostering Global Leaders and Daewoong Pharmaceutical ‘localization strategy'", Dong-A Ilbo(2019.05.16.), ~ (2019)
- Medipana, "Daewoong Pharmaceuticals, 10 trillion won for this year in Sales exceedingly", Medipana(2019.03.05.), ~ (2019)
- Chosun Ilbo, "Target Market by Securing Overseas ProductionBase", Chosun Ilbo(2017.10.27.), ~ (2017)
- Consumer-made Newspaper, "The Top 10 Pharmaceutical Companies Signboard Drugs of Sales Growing", Consumer-made Newspaper(2019.05.08.), ~ (2019)
- JoongAng Ilbo, "Daewoong Pharmaceutical and Research Control Tower Strengthened...Fostering Global Brands", JoongAng Ilbo(2013.03.11.), ~ (2013)
- Insight Korea, "Daewoong Pharmaceuticals and Strengthening the Global Healthcare Group as Localization Strategy", Insight Korea(2019.07.26.), ~ (2019)
- Palm Stock, "Recovering Pharmaceutical Holding Company, Surpassing Pharmaceutical Affiliated Company", Palm Stock(2017.06.02.), ~ (2017)
- Paxnet, "The Reorganization Promotion of Pharmaceutical Pricing System", Paxnet(2019.03.19.), ~ (2019)
- Prime Economy, "The Completion of the First Half of Unexpected Condition Inside Pharmaceutical Industry", Prime Economy(2019.07.17.), ~ (2019)
- The Daily Economy, "Daewoong Pharmaceuticals and Global Business Strengthened by Deploying Job Experts of Local Subsidiaries", The Daily Economy(2019.05.16.), ~ (2019)
- The Daily Economy, "Daewoong Pharmaceuticals and Completion of cGMP Level Smart Factory Osong Plan", Business Post, ~ (2017)
- The Korean Economy, "There are only 29 new drug developments in Korea over 100 years", The Korean Economy(2018.04.13.), ~ (2018)
- Yakup Newspaper, "Daewoong Pharmaceutical-Yoon Jae Seung Chairman", Yakup Newspaper(2006.09.20.), ~ (2006)